Systemic Inflammatory Response Syndrome in Elderly Patients with Acute Appendicitis: Age-Related Immune Changes and Perioperative Management

Trends in Immunotherapy

Article

Systemic Inflammatory Response Syndrome in Elderly Patients with Acute Appendicitis: Age-Related Immune Changes and Perioperative Management

Akhmatov, S., Baibulatov, E., Atakoziev, A., Adilet, A., Abdiev, A., Omorov, R., & Vityala, Y. (2025). Systemic Inflammatory Response Syndrome in Elderly Patients with Acute Appendicitis: Age-Related Immune Changes and Perioperative Management. Trends in Immunotherapy, 9(3), 282–292. https://doi.org/10.54963/ti.v9i3.1342

Authors

  • Sanzharbek Akhmatov

    Department of Surgery No. 3, City Clinical Hospital No. 1, Bishkek 720044, Kyrgyzstan
  • Eldar Baibulatov

    Vice-Rector for Strategic and Innovative Development of the International University of Kyrgyzstan, 720020 Kyrgyzstan
  • Azamat Atakoziev

    Department of Hospital and Operative Surgery named after academician M. Mamakeev, I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek 720020, Kyrgyzstan
  • Aitikeev Adilet

    Department of Clinical Work, Royal Metropolitan University, Bishkek 720010, Kyrgyzstan
  • Allan Abdiev

    Department of Faculty Surgery named after academician K.R. Ryskulova, I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek 720020, Kyrgyzstan
  • Rahatbek Omorov

    Department of Faculty Surgery named after academician K.R. Ryskulova, I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek 720020, Kyrgyzstan
  • Yethindra Vityala

    Department of Pathology, International Higher School of Medicine, Bishkek 720054, Kyrgyzstan

Received: 24 June 2025; Revised: 27 July 2025; Accepted: 7 September 2025; Published: 28 September 2025

Acute appendicitis is a common surgical issue with a lifetime risk of 7–8%. Prompt diagnosis is crucial to prevent complications, especially in elderly patients. Systemic Inflammatory Response Syndrome (SIRS) is a clinical condition characterized by widespread inflammation that can complicate appendicitis. This study examined the occurrence of SIRS across age groups, focusing on elderly patients, and assessed perioperative immune-modulating treatments. This retrospective study included 337 patients who underwent surgery for acute appendicitis. Patients were divided into four age categories: young adults (18–44 years), middle-aged adults (45–60 years), elderly (61–74 years), and senile (≥ 75 years). SIRS was identified using clinical criteria and examined in relation to patient age and type of appendicitis. Patients with SIRS (n = 207) received immunocorrective treatment, whereas the others received standard care. SIRS occurrence increased with age, from 32.3% in young adults to 100% in the senile group (p < 0.001). Elderly and senile patients met more SIRS criteria. SIRS was associated with appendicitis severity, reaching 100% in gangrenous peritonitis (p < 0.001). Patients with SIRS showed elevated inflammatory markers, including white blood cell count, C-reactive protein, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index. Immunocorrective treatment resulted in fewer complications (3.9%) than the typical rates for high-risk patients. This study showed an increase in SIRS incidence in elderly patients with acute appendicitis. The results revealed links between SIRS severity, age, and disease progression. The immunomodulatory protocol enhanced outcomes by reducing complications, particularly in elderly patients.

Keywords:

Systemic Inflammatory Response Syndrome Acute Appendicitis Immunosenescence Elderly Neutrophils

References

  1. Snyder, M.J.; Guthrie, M.; Cagle, S. Acute Appendicitis: Efficient Diagnosis and Management. Am. Fam. Physician. 2018, 98, 25–33.
  2. Humes, D.J.; Simpson, J. Acute Appendicitis. BMJ. 2006, 333, 530–534.
  3. Andersson, M.; Kolodziej, B.; Andersson, R.E.; et al. Randomized Clinical Trial of Appendicitis Inflammatory Response Score-Based Management of Patients With Suspected Appendicitis. Br. J. Surg. 2017, 104, 1451–1461.
  4. Davies, M.G.; Hagen, P.O. Systemic Inflammatory Response Syndrome. Br. J. Surg. 1997, 84, 920–935.
  5. Alonso de Vega, J.M.; Díaz, J.; Serrano, E.; et al. Oxidative Stress in Critically Ill Patients With Systemic Inflammatory Response Syndrome. Crit. Care Med. 2002, 30, 1782–1786.
  6. Ng, K.C.; Lai, S.W. Clinical Analysis of the Related Factors in Acute Appendicitis. Yale J. Biol. Med. 2002, 75, 41–45.
  7. Drifte, G.; Dunn-Siegrist, I.; Tissières, P.; et al. Innate Immune Functions of Immature Neutrophils in Patients With Sepsis and Severe Systemic Inflammatory Response Syndrome. Crit. Care Med. 2013, 41, 820–832.
  8. Paajanen, H.; Mansikka, A.; Laato, M.; et al. Are Serum Inflammatory Markers Age Dependent in Acute Appendicitis? J. Am. Coll. Surg. 1997, 184, 303–308.
  9. Şener, K.; Çakır, A.; Kılavuz, H.; et al. Diagnostic Value of Systemic Immune Inflammation Index in Acute Appendicitis. Rev. Assoc. Med. Bras. 2023, 69, 291–296.
  10. Rangel-Frausto, M.S.; Pittet, D.; Costigan, M.; et al. The Natural History of the Systemic Inflammatory Response Syndrome (SIRS): A Prospective Study. JAMA. 1995, 273, 117–123.
  11. de Jong, H.K.; van der Poll, T.; Wiersinga, W.J. The Systemic Pro-Inflammatory Response in Sepsis. J. Innate Immun. 2010, 2, 422–430.
  12. Matsuda, N.; Hattori, Y. Systemic Inflammatory Response Syndrome (SIRS): Molecular Pathophysiology and Gene Therapy. J. Pharmacol. Sci. 2006, 101, 189–198.
  13. Zacharowski, K.; Zacharowski, P.A.; Koch, A.; et al. Toll-Like Receptor 4 Plays a Crucial Role in the Immune-Adrenal Response to Systemic Inflammatory Response Syndrome. Proc. Natl. Acad. Sci. 2006, 103, 6392–6397.
  14. van der Poll, T.; Meijers, J.C. Systemic Inflammatory Response Syndrome and Compensatory Anti-Inflammatory Response Syndrome in Sepsis. J. Innate Immun. 2010, 2, 379–380.
  15. Torre, D.; Tambini, R.; Aristodemo, S.; et al. Anti-Inflammatory Response of IL-4, IL-10 and TGF-Beta in Patients With Systemic Inflammatory Response Syndrome. Mediators Inflamm. 2000, 9, 193–195.
  16. Bom, W.J.; Scheijmans, J.C.G.; Salminen, P.; et al. Diagnosis of Uncomplicated and Complicated Appendicitis in Adults. Scand. J. Surg. 2021, 110, 170–179.
  17. Cunha, L.L.; Perazzio, S.F.; Azzi, J.; et al. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response. Front. Immunol. 2020, 11, 1748.
  18. Pinti, M.; Appay, V.; Campisi, J.; et al. Aging of the Immune System: Focus on Inflammation and Vaccination. Eur. J. Immunol. 2016, 46, 2286–2301.
  19. Gürleyik, G.; Gürleyik, E. Age-Related Clinical Features in Older Patients With Acute Appendicitis. Eur. J. Emerg. Med. 2003, 10, 200–203.
  20. Bone, R.C.; Balk, R.A.; Cerra, F.B.; et al. Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis. Chest 1992, 101, 1644–1655.
  21. Bhangu, A.; Søreide, K.; Di Saverio, S.; et al. Acute Appendicitis: Modern Understanding of Pathogenesis, Diagnosis, and Management. Lancet. 2015, 386, 1278–1287.
  22. Guller, U.; Hervey, S.; Purves, H.; et al. Laparoscopic Versus Open Appendectomy: Outcomes Comparison Based on a Large Administrative Database. Ann. Surg. 2004, 239, 43–52.
  23. Bion, J.F. Susceptibility to Critical Illness: Reserve, Response and Therapy. Intensive Care Med. 2000, 26, S57–S63.
  24. Fülöp, T.; Larbi, A.; Pawelec, G. Human T Cell Aging and the Impact of Persistent Viral Infections. Front. Immunol. 2013, 4, 271.
  25. Franceschi, C.; Campisi, J. Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases. J. Gerontol. 2014, 69, S4–S9.
  26. Chinn, I.K.; Blackburn, C.C.; Manley, N.R.; et al. Changes in Primary Lymphoid Organs With Aging. Semin. Immunol. 2012, 24, 309–320.
  27. Póvoa, P.; Salluh, J.I. Biomarker-Guided Antibiotic Therapy in Adult Critically Ill Patients: A Critical Review. Ann. Intensive Care. 2012, 2, 32.
  28. Zimmermann, P.; Curtis, N. Why Is COVID-19 Less Severe in Children? A Review of the Proposed Mechanisms Underlying the Age-Related Difference in Severity of SARS-CoV-2 Infections. Arch. Dis. Child. 2021, 106, 429–439.
  29. Yethindra, V.; Tagaev, T. Decreased Mortality Among Hospitalized Coronavirus Disease 2019 Patients Who Underwent Anticoagulant Therapy With Heparin. Indian J. Pharmacol. 2020, 52, 337–338.
  30. Kadyrova, A.; Antipina, I.; Kyrbasheva, I.; et al. CT Patterns and Differential Criteria for Acute Eosinophilic Pneumonia and COVID-19 Pneumonia. Clin. Case Rep. 2021, 9, e04890.
  31. Beltrán, M.A. The Systemic Inflammatory Response in Patients With Appendicitis: A Progressive Phenomenon. Indian J. Surg. 2015, 77, 1050–1056.
  32. Sartelli, M.; Baiocchi, G.L.; Di Saverio, S.; et al. Prospective Observational Study on Acute Appendicitis Worldwide (POSAW). World J. Emerg. Surg. 2018, 13, 19.
  33. Andersson, R.E. The Natural History and Traditional Management of Appendicitis Revisited: Spontaneous Resolution and Predominance of Prehospital Perforations Imply That a Correct Diagnosis Is More Important Than an Early Diagnosis. World J. Surg. 2007, 31, 86–92.
  34. Takeuchi, O.; Akira, S. Pattern Recognition Receptors and Inflammation. Cell 2010, 140, 805–820.
  35. Abdiev, A.; Arsen, T.; Ulan, I.; et al. Relaparotomy for Peritonitis Following Liver Surgery in Alveococcosis and Echinococcosis: A Retrospective Analysis of 924 Cases. J. Commun. Dis. 2024, 56, 153–157.
  36. Liu, J.; Li, S.; Zhang, S.; et al. Systemic Immune-Inflammation Index, Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio Can Predict Clinical Outcomes in Patients With Metastatic Non-Small-Cell Lung Cancer Treated With Nivolumab. J. Clin. Lab. Anal. 2019, 33, e22964.
  37. Kumar, V.; Sharma, A. Neutrophils: Cinderella of Innate Immune System. Int. Immunopharmacol. 2010, 10, 1325–1334.
  38. Delano, M.J.; Ward, P.A. Sepsis-Induced Immune Dysfunction: Can Immune Therapies Reduce Mortality? J. Clin. Invest. 2016, 126, 23–31.
  39. Kellum, J.A.; Kong, L.; Fink, M.P.; et al. Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. JAMA Intern. Med. 2007, 167, 1655–1663.
  40. Partridge, J.S.; Harari, D.; Martin, F.C.; et al. The Impact of Pre-Operative Comprehensive Geriatric Assessment on Postoperative Outcomes in Older Patients Undergoing Scheduled Surgery: A Systematic Review. Anaesthesia. 2014, 69, 8–16.
  41. Hotchkiss, R.S.; Monneret, G.; Payen, D. Immunosuppression in Sepsis: A Novel Understanding of the Disorder and a New Therapeutic Approach. Lancet Infect. Dis. 2013, 13, 260–268.
  42. Rello, J.; Valenzuela-Sánchez, F.; Ruiz-Rodriguez, M.; et al. Sepsis: A Review of Advances in Management. Adv. Ther. 2017, 34, 2393–2411.
  43. Angus, D.C.; van der Poll, T. Severe Sepsis and Septic Shock. N. Engl. J. Med. 2013, 369, 840–851.
  44. Mahmood, A.; Raza, S.H.; Elshaikh, E.; et al. Acute Appendicitis in People Living With HIV: What Does the Emergency Surgeon Need to Know? SAGE Open Med. 2021, 9, 2050312120982461.
  45. Maschmeyer, G.; De Greef, J.; Mellinghoff, S.C.; et al. Infections Associated With Immunotherapeutic and Molecular Targeted Agents in Hematology and Oncology: A Position Paper by the European Conference on Infections in Leukemia (ECIL). Leukemia. 2019, 33, 844–862.
  46. Nolt, B.; Tu, F.; Wang, X.; et al. Lactate and Immunosuppression in Sepsis. Shock. 2018, 49, 120–125.